| Literature DB >> 36167583 |
Zahra Mahmoudvand1, Mostafa Shanbehzadeh2, Mohsen Shafiee3, Hadi Kazemi-Arpanahi4,5.
Abstract
BACKGROUND: Corrosive ingestion is still a major health problem, and its outcomes are often unpredicted. The implementation of a registry system for poisoning with corrosive substances may improve the quality of patient care and might be useful to manage this type of poisoning and its complications. Therefore, our study aimed to establish a minimum data set (MDS) for corrosive ingestion.Entities:
Keywords: Acids; Alkalis; Caustics; Common data elements; Poisoning; Registries
Mesh:
Substances:
Year: 2022 PMID: 36167583 PMCID: PMC9513958 DOI: 10.1186/s12913-022-08576-0
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.908
Fig. 1Search flow diagram
Poisoning databases/datasets
| First author | Country | MDS use case | Data classes | Number of data elements |
|---|---|---|---|---|
| Robinson et al. [ | Australia | Poisoning information system | Demographic, exposure factors, signs and symptoms, past medical history, current treatments, and counseling | 126 |
| Sabahi et al. [ | Iran | Poisoning registry system | Clinical section: diagnostic tests, prescription drugs, physical examinations, past medical history,therapeutics procedures, laboratory tests. Administrative section: sociodemographic, lifestyle, contact, and legal | 358 |
| Waston et al. [ | United States | Toxic exposure surveillance system (TESS) | Patient information, exposure information/ substance, clinical impacts (toxic effects), treatment, and medical results | –- |
| Ekpe et al. [ | Australia | Record data in hunter area toxicology service (HATS) | Demographics, exposure data, presentation information, past medical history, clinical examinations, psychiatric consultations, treatment plans, patient outcomes, discharge, and follow-up information | 88 |
| Yazdipour et al. [ | Iran | Iranian poisoning registry system | Demographics, patient and communication data, encounter data, diagnostic tests, medical history, exposure data, complications, clinical& treatment plans, paraclinical tests, biobank, and discharge data | 558 |
| Whyte et al. [ | United States | ToxIC registry | Identifiers, encounter data, exposure data, agent data, clinical manifestations, sign and symptoms, and diagnostic& treatment data | 48 |
| -[ | WHO | International toxicology (INTOX) software | Demographics, exposure data, clinical manifestations, referring data, laboratory tests, patient outcomes, and treatment plans | 32 |
| Gohari et al. [ | Iran | Iranian poisoning registry | Clinical section: diagnostic information, exposure information, medical history, clinical findings, diagnostic intervention, and treatment information Non-clinical section: demographic information, presentation information, and discharge information | 113 |
| Contini et al. [ | United States | MDS of the national poison registry system (NPDS) | Socio-demographical, exposure information, clinical findings, patient history, vital signs, physical examinations, diagnostic interventions, complications, clinical syndromes, care plans, follow-up, and medical outcomes | 65 |
An example of the results of the Delphi phases and CVI calculation for two categories (administrative and clinical)
| Administrative class | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Patients ID | 50.66% | 24.67% | 24.67% | 38 | 0.51 | Remove | |||
| Age | 100 | 0 | 0 | 75 | 1 | Kept | |||
| Gender | 97.34% | 0 | 2.66% | 75 | 1 | Kept | |||
| Admission date | 76% | 20% | 4% | 80% | 16% | 4% | 70 | 0.94 | Kept |
| Employment status | 33.75% | 33.125% | 33.125% | 42 | 0.56 | Remove | |||
| Residence (housing) | 92% | 5.33% | 2.67% | 68 | 0.906 | Kept | |||
| Income | 100 | 0 | 0 | 75 | 1 | Kept | |||
| Date of birth | 97.33% | 2.67% | 0 | 72 | 0.96 | Kept | |||
| Marital status | 92% | 5.33% | 2.67% | 75 | 1 | Kept | |||
| Ethnicity | 86.66% | 9.33% | 4.01% | 70 | 0.933 | Kept | |||
| Height | 90.66% | 6.66% | 2.68% | 69 | 0.92 | Kept | |||
| Weight | 94.66% | 5.34% | 0 | 74 | 0.986 | Kept | |||
| National code | 46.66% | 36.67% | 16.67% | 35 | 0.47 | Remove | |||
| Religion | 100% | 0 | 0 | 68 | 0.906 | Kept | |||
| Education level | 100% | 0 | 0 | 67 | 0.893 | Kept | |||
| Occupation | 100% | 0 | 0 | 75 | 1 | Kept | |||
| Patient's phone number | 100% | 0 | 0 | 30 | 0.4 | Remove | |||
| Patient home address | 36.66% | 46.67% | 16.67% | 32 | 0.43 | Remove | |||
| 44% | 56% | 0 | 33 | 0.44 | Remove | ||||
| Hospital name | 44% | 56% | 0 | 33 | 0.44 | Remove | |||
| Hospital address | 40% | 22.5% | 37.5% | 30 | 0.4 | Remove | |||
| Type of referring to the hospital | 100% | 0 | 0 | 75 | 1 | Kept | |||
| Dealing with toxin | 100% | 0 | 0 | 74 | 0.986 | Kept | |||
| Duration of hospitalization | 77.33% | 12% | 10.67% | 75 | 1 | Kept | |||
| Admission time | 85.33% | 10.66% | 4.01% | 67 | 0.893 | Kept | |||
| Patients’ status after discharge | 100% | 0 | 0 | 75 | 1 | Kept | |||
| Date of follow-up | 100% | 0 | 0 | 75 | 1 | Kept | |||
| Discharge outcome | 100% | 0 | 0 | 75 | 1 | Kept | |||
| Ingested substance | 85.33% | 10.66% | 4.01% | 73 | 0.973 | Kept | |||
| Volume of ingestion | 77.33% | 12% | 10.67% | 75 | 1 | Kept | |||
| Physical characteristics of substances | 86.66% | 9.33% | 4.01% | 70 | 0.933 | Kept | |||
| Amount of substance | 93.33% | 6.67% | 0 | 75 | 1 | Kept | |||
| Concentration of substance | 96% | 4% | 0% | 72 | 0.96 | Kept | |||
| Duration time between swallowing until arrival at the hospital | 100% | 0 | 0 | 75 | 1 | Kept | |||
| Measures taken before and during transportation to a medical center | 60% | 26.66% | 13.34% | 82% | 11.33% | 6.67% | 65 | 0.866 | Kept |
An example of the calculation of CVR, modified kappa, and face validity for two categories (administrative class and corrosive poisoning subclass)
| Age | 75 | 1 | 0/009× | 1 | 3.5 | Excellent |
| Gender | 75 | 1 | ~ 0 | 1 | 3.5 | Excellent |
| Admission date | 70 | 0.94 | ~ 0 | 0.94 | 3.5 | Excellent |
| Residence (housing) | 68 | 0.906 | ~ 0 | 0.906 | 3.18 | Excellent |
| Income | 75 | 1 | ~ 0 | 1 | 3.5 | Excellent |
| Date of birth | 72 | 0.96 | ~ 0 | 0.96 | 3.5 | Excellent |
| Marital status | 75 | 1 | ~ 0 | 1 | 3.5 | Excellent |
| Ethnicity | 70 | 0.933 | ~ 0 | 0.94 | 2.09 | Excellent |
| Height | 69 | 0.92 | ~ 0 | 0.92 | 3.5 | Excellent |
| Weight | 74 | 0.986 | ~ 0 | 0.986 | 3.01 | Excellent |
| Religion | 72 | 0.96 | ~ 0 | 0.96 | 3.18 | Excellent |
| Education level | 75 | 1 | ~ 0 | 1 | 3.5 | Excellent |
| Occupation | 70 | 0.933 | ~ 0 | 0.933 | 3.04 | Excellent |
| Type of referring to the hospital | 69 | 0.92 | ~ 0 | 0.92 | 3.1 | Excellent |
| Dealing with toxin | 75 | 1 | ~ 0 | 1 | 3.3 | Excellent |
| Duration of hospitalization | 74 | 0.986 | ~ 0 | 0.986 | 3.1 | Excellent |
| Admission time | 75 | 1 | ~ 0 | 1 | 2.89 | Excellent |
| Patients’ status after discharge | 67 | 0.893 | ~ 0 | 0.893 | 3.01 | Excellent |
| Date of follow-up | 75 | 1 | ~ 0 | 1 | 2.94 | Excellent |
| Discharge outcome | 75 | 1 | ~ 0 | 1 | 3.04 | Excellent |
| Ingested substance | 73 | 0.973 | ~ 0 | 0.973 | 3.3 | Excellent |
| Volume of ingestion | 75 | 1 | ~ 0 | 1 | 3.2 | Excellent |
| Physical characteristics of substances | 70 | 0.933 | ~ 0 | 0.933 | 3.4 | Excellent |
| Amount of substance | 75 | 1 | ~ 0 | 1 | 3.5 | Excellent |
| Concentration of substance | 72 | 0.96 | ~ 0 | 0.96 | 3.5 | Excellent |
| Duration time between swallowing until arrival at the hospital | 75 | 1 | ~ 0 | 1 | 3.5 | Excellent |
| Measures taken before and during transportation to a medical center | 65 | 0.866 | ~ 0 | 0.866 | 3.5 | Excellent |
aThe formula of content validity ratio is CVR = (Ne—N/2)/ (N/2). In which the Ne is the number of panelists indicating "essential" and N is the total number of panelists. The numeric value of content validity ratio is determined by Lawshe Table. if CVR is bigger than 0.49, the item in the instrument with an acceptable level of significance will be accepted
bPc (probability of a chance occurrence) was computed using the formula: pc = [N! /A! (N -A)!] *.5Nwhere N = number of experts and A = number of panelists who agree that the item is relevant
cK (Modified Kappa) was computed using the formula: K = (I-CVI- PC)/ (1- PC). Interpretation criteria for Kappa, using guidelines described in Cicchetti and Sparrow (1981): Fair = K of 0.40 to 0.59; Good = K of 0.60 to 0.74; and Excellent = K > 0.7
dFor calculation, the formula Impact Score = frequency (ratio of raters who scored 3 & 4) * Importance (mean score for the importance on the basis of domains) was used. The Impact Score for each item must be above 1.5 or it will be removed
Ratings of the items by 75 experts: items rated 3 or 4 on a 4-point relevance scale (for example)
| Data class | Data items | The number of experts | I-CVIs | S-CVI/UA | S-CVI/Ave |
|---|---|---|---|---|---|
| Administrative | Age | 75 | 1 | S-CVI: 0.92 S-CVI/UA: 0.49 | S-CVI/Ave: 0.936 |
| Gender | 75 | 1 | |||
| Admission date | 70 | 0.94 | |||
| Residence (housing) | 68 | 0.906 | |||
| Income | 75 | 1 | |||
| Date of birth | 72 | 0.96 | |||
| Marital status | 75 | 1 | |||
| Ethnicity | 70 | 0.933 | |||
| Height | 69 | 0.92 | |||
| Weight | 74 | 0.986 | |||
| Religion | 72 | 0.96 | |||
| Education level | 75 | 1 | |||
| Occupation | 70 | 0.933 | |||
| Type of referring to the hospital | 69 | 0.92 | |||
| Dealing with toxin | 75 | 1 | |||
| Duration of hospitalization | 74 | 0.986 | |||
| Admission time | 75 | 1 | |||
| Patients’ status after discharge | 67 | 0.893 | |||
| Date of follow-up | 75 | 1 | |||
| Discharge outcome | 75 | 1 | |||
| Clinical (corrosive poisoning subclass) | Ingested substance name | 73 | 0.973 | S-CVI: 0.94 S-CVI/UA: 0.48 | S-CVI/Ave: 0.948 |
| Volume of ingestion | 75 | 1 | |||
| Physical characteristics of Substances | 70 | 0.933 | |||
| Amount of substance | 75 | 1 | |||
| Concentration of substance | 72 | 0.96 | |||
| Duration time between ingestion until arrival at the hospital | 75 | 1 | |||
| Measures are taken before and during dispatch to a medical center | 65 | 0.866 |
Administrative class
| Subclass | Data items |
|---|---|
| Socio-demographic | Age, gender, residence (housing), income, date of birth, marital status, ethnicity, height, weight, religion, education level, occupation |
| Admission and discharge (A&D) information | Type of referring to the hospital, dealing with toxin, admission date, admission time, duration of hospitalization, discharge outcome, patients’ status after discharge, date of follow-up |
Clinical class
| Main Category | Sub-class | Data items |
|---|---|---|
| Medical history | Drug and substances consumption history | Drug use, alcohol consumption, smoking cigarette |
| Comorbidities | Central nervous system (CNS) diseases, cardiovascular diseases (CVD), pulmonary diseases, GI diseases, hepatic disease, renal diseases, skin diseases, muscle-skeletal diseases, hemorrhagic disorders, endocrine disorders, mental disorders | |
| Family history | Mental disorders, drug consumption | |
| History of poisoning | Substance name, number of encounters, cause of exposure | |
| Poisoning | Corrosive ingestion | Name of ingested substance, the volume of ingestion, physical characteristics of substances, amount of substance, the concentration of a substance, duration time between ingestion until arrival at the hospital, measures taken before and during transportation to a medical center |
| Clinical manifestations | CNS manifestations | Coma, delusions, confusion, hallucination, movement disorder, body tremor, myoclonus, level of consciousness, headache, vertigo, convulsions, drowsiness, body temperature changes |
| Cardiovascular manifestations | Paroxysmal supraventricular tachycardia (PSVT), extending the QT interval, wide QRS, dysrhythmia, chest pain, blood pressure (BP) disorder, heart rate disorder (tachycardia and bradycardia) | |
| GI and liver manifestations | Tenderness, diarrhea, abdominal pain, bloody stools, rebound, reflux or gastritis, GI bleeding, liver problems, abdominal rigidity, burned lips, burning of the oral mucosa, taste change in the mouth, tongue edema, pharynx and larynx edema, erythema of the mucous membranes, mouth ulcers, sialorrhea, dysphagia, nausea | |
| Pulmonary manifestations | Airway edema, respiratory rate changes (tachypnea or brady-pnea), aspiration pneumonia, hoarseness, coughing, stertorous, dyspnea, cyanosis, acute lung injury, chemical pneumonitis, wheezing, acute respiratory distress syndrome (ARDS), hemoptysis, crackle, rales | |
| Skin and eye manifestations | Facial skin burns, pain at the contact site, burns at the contact site, eczema or rash, angioedema, blister, vesicle, necrosis, abnormal bleeding and bruising, erythema | |
| Metabolic status | Increased osmotic gap, increased anion gap, hypoglycemia, metabolic acidosis, metabolic alkalosis | |
| Complications | Bleeding, perforation, fistula, esophagus obstruction, mediastinitis, peritonitis, kidney failure, liver dysfunction, hemolysis | |
| Diagnosis tests | Laboratory investigations | Atrial blood gases (ABG), white blood cells (WBC), hemoglobin (hb), hematocrit (HCT), platelet count, retic, lactate, blood sugar (BS), base excess, venus blood gaz (VBG), blood urea nitrogen (BUN), creatinine, sodium, potassium, magnesium, anion gap, troponin, ammonia, creatine kinase (CK), creatine phosphokinase (CPK), prothrombin time (PT), partial thromboplastin time (PTT), international normalize ratio (INR), alanine aminotransferase (ALT), aspartate aminotransferase (AST) |
| Para-clinical investigations | Endoscopy, X-ray, CT-scan | |
| Therapeutic interventions | Supportive treatment | Transfusion blood, intravenous (IV) infusion, gavage, airway management, shock management, Oxygen (O2) therapy, esophageal stent |
| Prescription medicine | Steroid, antibiotic, antiacid, analgesics | |
| Type of intervention | Gegeostomy feeding, laparotomy, gastrectomy, esophagectomy, colon interposition, gastric polyp surgery, bougienage | |